// App-Quantinova.ai

TP428 2016 ASA : Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior Stroke in GLORIA- AF Phase II (Global Registry on Long-term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation, Phase II)

Researchers

Presenter

  • Menno V Huisman

Principal Investigators

  • Jonathan L Halperin

  • Greg Y Lip

  • Dorothee Bartels

  • Sergio J Dubner

  • Chang S Ma

  • Kenneth J Rothman

  • Kristina Zint

  • Amelie Elsaesser

  • Miney Paquette

  • Christine Teutsch

Medical Centers

  • University Hospital of Essen, Essen, Germany

  • Univ of Birmingham Cntr for Cardiovascular Sciences, Birmingham, United Kingdom

  • Mount Sinai Medical Center, New York, NY

  • Leiden University Medical Centre, Leiden, Netherlands

  • Clinica y Maternidad Suizo Argentina, Buenso Aires, Argentina

  • Boston University School of Public Health, Boston, MA

  • Burlington,Canada

  • Beijing Anzhen Hosp, Beijing, China

Locations

  • Canada

  • China

  • Argentina

  • Netherlands

  • Germany

  • United Kingdom

  • United States

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Arrhythmia

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim